Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continued Access Study of the InterGraft™ Venous Anastomotic Connector for Minimally Invasive Connection of an Arteriovenous Graft for Hemodialysis

NCT05448950 is registered in ClinicalTrials.gov with Phraxis, Inc. as lead sponsor.

NCT NCT05448950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05448950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continued Access Study of the InterGraft™ Venous Anastomotic Connector for Minimally Invasive Connection of an Arteriovenous Graft for Hemodialysis
Lead sponsor
Phraxis, Inc.
Phase
Not applicable
Overall status
Completed
Start date
June 7, 2022
Completion date
March 8, 2023
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dialysis access malfunction